jueves, 31 de marzo de 2022

Israel has 130 innovation, tech companies geared for women - ISRAEL21c

Israel has 130 innovation, tech companies geared for women - ISRAEL21c

This tech will cut the cost of self-funded health coverage - ISRAEL21c

This tech will cut the cost of self-funded health coverage - ISRAEL21c

The Good, the Bad and the Ugly: New FDA Legislative Proposal on 180-Day Exclusivity (Both “the Bad” and “the Ugly”)

The Good, the Bad and the Ugly: New FDA Legislative Proposal on 180-Day Exclusivity (Both “the Bad” and “the Ugly”)

Study models the airborne transmission of COVID-19 in a hospital outpatient examination room

Study models the airborne transmission of COVID-19 in a hospital outpatient examination room

Study estimates the comparative abundance of SARS-CoV-2 variants via wastewater monitoring

Study estimates the comparative abundance of SARS-CoV-2 variants via wastewater monitoring

Medical News | Medical Articles

Medical News | Medical Articles

"Mental Health at Work: What Can I Do" PSA - What Can YOU Do?

"Mental Health at Work: What Can I Do" PSA - What Can YOU Do?

Report: More than 600 medicines in development for diseases affecting women

Report: More than 600 medicines in development for diseases affecting women

CDRHNew - News and Updates | FDA

CDRHNew - News and Updates | FDA

Law enforcement seizures of pills containing fentanyl increased dramatically between 2018-2021 | National Institutes of Health (NIH)

Law enforcement seizures of pills containing fentanyl increased dramatically between 2018-2021 | National Institutes of Health (NIH)

Explained: Why is China seeing a spike in Covid-19 cases, and should India worry? | Explained News,The Indian Express

Explained: Why is China seeing a spike in Covid-19 cases, and should India worry? | Explained News,The Indian Express

Medication safety in the emergency department: a study of serious medication errors reported by 101 hospitals from 2011 to 2020. | PSNet

Medication safety in the emergency department: a study of serious medication errors reported by 101 hospitals from 2011 to 2020. | PSNet

Pharmacist transition-of-care services improve patient satisfaction and decrease hospital readmissions. | PSNet

Pharmacist transition-of-care services improve patient satisfaction and decrease hospital readmissions. | PSNet

Preventing delayed and missed care by applying artificial intelligence to trigger radiology imaging follow-up. | PSNet

Preventing delayed and missed care by applying artificial intelligence to trigger radiology imaging follow-up. | PSNet

FDA’s Technology and Data Modernization in Action in 2022 | FDA

FDA’s Technology and Data Modernization in Action in 2022 | FDA

HCUP Workshops and Webinars: Register Today for HCUP’S Virtual Data Users’ Workshop on April 27-28

HCUP Workshops and Webinars

Guidance for Industry: Discuss the draft guidance for industry, Immunogenicity Information in Human Prescription Therapeutic Protein and Select Drug Product Labeling — Content and Format (February 2022). When final, this guidance will represent FDA’s current thinking on this topic.

Guidance for Industry

Immunogenicity Information in Labeling - 04/05/2022 | FDA

Immunogenicity Information in Labeling - 04/05/2022 | FDA

What’s New for Biologics | FDA

What’s New for Biologics | FDA

Pharmaceutical Quality/Chemistry, Manufacturing & Controls (PQ/CMC) | FDA

Pharmaceutical Quality/Chemistry, Manufacturing & Controls (PQ/CMC) | FDA

FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for medical imaging | FDA

FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for medical imaging | FDA

FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding | FDA

FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding | FDA

Hospice Center | CMS

Hospice Center | CMS

Federal Register :: Public Inspection: Medicare Program: FY 2023 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirements

Federal Register :: Public Inspection: Medicare Program: FY 2023 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirements

miércoles, 30 de marzo de 2022

Research on Integrating Social & Medical Care | SIREN

Research on Integrating Social & Medical Care | SIREN

National Research Meeting | SIREN

National Research Meeting | SIREN

Association between operative autonomy of surgical residents and patient outcomes. | PSNet

Association between operative autonomy of surgical residents and patient outcomes. | PSNet

Patient harm and institutional avoidability of out-of-hours discharge from intensive care: an analysis using mixed methods. | PSNet

Patient harm and institutional avoidability of out-of-hours discharge from intensive care: an analysis using mixed methods. | PSNet

Error reduction in trauma care: Lessons from an anonymized, national, multicenter mortality reporting system. | PSNet

Error reduction in trauma care: Lessons from an anonymized, national, multicenter mortality reporting system. | PSNet

Notice of Funding Opportunities | Agency for Healthcare Research and Quality

Notice of Funding Opportunities | Agency for Healthcare Research and Quality

NOT-HS-22-011: AHRQ Announces Interest in Primary Care Research

NOT-HS-22-011: AHRQ Announces Interest in Primary Care Research

technical landscape for patient-centered CDS: progress, gaps, and challenges | Journal of the American Medical Informatics Association | Oxford Academic

technical landscape for patient-centered CDS: progress, gaps, and challenges | Journal of the American Medical Informatics Association | Oxford Academic

Nursing Home COVID-19 Action Network | Agency for Healthcare Research and Quality

Nursing Home COVID-19 Action Network | Agency for Healthcare Research and Quality

Best Practices for Promoting Emotional Well-Being in Nursing Home Residents

Best Practices for Promoting Emotional Well-Being in Nursing Home Residents

Best Practices for Promoting Mental Health and Emotional Well-Being Among Nursing Home Staff

Best Practices for Promoting Mental Health and Emotional Well-Being Among Nursing Home Staff

Best Practices Guide for COVID-19 Infection Control and Prevention in Nursing Homes

Best Practices Guide for COVID-19 Infection Control and Prevention in Nursing Homes

Best Practice Summaries | Agency for Healthcare Research and Quality

Best Practice Summaries | Agency for Healthcare Research and Quality

Implementation of an Antibiotic Stewardship Program in Long-term Care Facilities Across the US - PubMed

Implementation of an Antibiotic Stewardship Program in Long-term Care Facilities Across the US - PubMed

An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees - PubMed

An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees - PubMed

Parent Experience and Cost Savings Associated With a Novel Tele-physiatry Program for Children Living in Rural and Underserved Communities - PubMed

Parent Experience and Cost Savings Associated With a Novel Tele-physiatry Program for Children Living in Rural and Underserved Communities - PubMed

The Impact of a Population-Based System of Care Intervention on Enhanced Prenatal Care and Service Utilization Among Medicaid-Insured Pregnant Women - PubMed

The Impact of a Population-Based System of Care Intervention on Enhanced Prenatal Care and Service Utilization Among Medicaid-Insured Pregnant Women - PubMed

Coronavirus disease 2019 (COVID-19) in assisted living communities: Neighborhood deprivation and state social distancing policies matter - PubMed

Coronavirus disease 2019 (COVID-19) in assisted living communities: Neighborhood deprivation and state social distancing policies matter - PubMed

Health Care Use and Outcomes in Assisted Living Communities: Race, Ethnicity, and Dual Eligibility - PubMed

Health Care Use and Outcomes in Assisted Living Communities: Race, Ethnicity, and Dual Eligibility - PubMed

Using Medicare Enrollment Data to Identify Beneficiaries in Assisted Living - PubMed

Using Medicare Enrollment Data to Identify Beneficiaries in Assisted Living - PubMed

The Imperative to Reimagine Assisted Living - PubMed

The Imperative to Reimagine Assisted Living - PubMed

Risks of Bariatric Surgery Among Patients With End-stage Renal Disease - PubMed

Risks of Bariatric Surgery Among Patients With End-stage Renal Disease - PubMed

Design and study protocol for a cluster randomized trial of a multi-faceted implementation strategy to increase the uptake of the USPSTF hypertension screening recommendations: the EMBRACE study - PubMed

Design and study protocol for a cluster randomized trial of a multi-faceted implementation strategy to increase the uptake of the USPSTF hypertension screening recommendations: the EMBRACE study - PubMed

Importance of long-term follow-up after endoscopic management for upper tract urothelial carcinoma and factors leading to surgical management - PubMed

Importance of long-term follow-up after endoscopic management for upper tract urothelial carcinoma and factors leading to surgical management - PubMed

Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study - PubMed

Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study - PubMed

2021 National Healthcare Quality and Disparities Report

2021 National Healthcare Quality and Disparities Report

CDRHNew - News and Updates | FDA

CDRHNew - News and Updates | FDA

Opportunity for Public Comment | United States Preventive Services Taskforce: Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Sleep Apnea

Opportunity for Public Comment | United States Preventive Services Taskforce

Vibha Krishnamurthy writes: For kids with disabilities, the pandemic may have been a reprieve

Vibha Krishnamurthy writes: For kids with disabilities, the pandemic may have been a reprieve

Do I qualify for a COVID-19 vaccine booster and which one? | FDA

Do I qualify for a COVID-19 vaccine booster and which one? | FDA

Do I qualify for a COVID-19 vaccine booster and which one? | FDA

Do I qualify for a COVID-19 vaccine booster and which one? | FDA

Spikevax and Moderna COVID-19 Vaccine | FDA

Spikevax and Moderna COVID-19 Vaccine | FDA

Comirnaty and Pfizer-BioNTech COVID-19 Vaccine | FDA

Comirnaty and Pfizer-BioNTech COVID-19 Vaccine | FDA

Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals | FDA

Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals | FDA

Proposed Legislation Would Reverse Genus Decisions

Proposed Legislation Would Reverse Genus Decisions

martes, 29 de marzo de 2022

Sharing rebates can save Americans with diabetes $500 each year and improve adherence, especially for Black and Hispanic Americans

Sharing rebates can save Americans with diabetes $500 each year and improve adherence, especially for Black and Hispanic Americans

PharmaBoardroom - PhRMA Chair on What Health Equity Means to Biopharma

PharmaBoardroom - PhRMA Chair on What Health Equity Means to Biopharma

Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals

Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals Dear International Colleague, Today, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second booster dose of these vaccines available to other populations at higher risk for severe disease, hospitalization and death. Emerging evidence suggests that a second booster dose of an mRNA COVID-19 vaccine improves protection against severe COVID-19 and is not associated with new safety concerns. The agency amended the emergency use authorizations as follows: A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise. A second booster dose of the Moderna COVID-19 Vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise. “Current evidence suggests some waning of protection over time against serious outcomes from COVID-19 in older and immunocompromised individuals. Based on an analysis of emerging data, a second booster dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine could help increase protection levels for these higher-risk individuals,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “Additionally, the data show that an initial booster dose is critical in helping to protect all adults from the potentially severe outcomes of COVID-19. So, those who have not received their initial booster dose are strongly encouraged to do so.” Today’s action applies only to the Pfizer-BioNTech and Moderna COVID-19 vaccines and the authorization of a single booster dose for other age groups with these vaccines remains unchanged. The agency will continue to evaluate data and information as it becomes available when considering the potential use of a second booster dose in other age groups. The FDA-authorized Pfizer-BioNTech COVID-19 Vaccine and the FDA-approved Comirnaty can be used to provide the authorized booster dose(s). Similarly, the FDA-authorized Moderna COVID-19 Vaccine and the FDA-approved Spikevax are authorized to provide the authorized booster dose(s). Information to Support Authorization of a Second COVID-19 Booster Dose The FDA has determined that the known and potential benefits of a second COVID-19 vaccine booster dose with either of these vaccines outweigh their known and potential risks in these populations. The evidence considered for authorization of a second booster dose following primary vaccination and first booster dose included safety and immune response information provided to the agency as well as additional information on effectiveness submitted by the companies. A summary of safety surveillance data provided to the FDA by the Ministry of Health of Israel on the administration of approximately 700,000 fourth (second booster) doses of the Pfizer-BioNTech COVID-19 Vaccine given at least 4 months after the third dose in adults 18 years of age and older (approximately 600,000 of whom were 60 years of age or older) revealed no new safety concerns. The safety of Moderna COVID-19 Vaccine, when administered as a second booster dose, is informed by experience with the Pfizer-BioNTech COVID-19 Vaccine and safety information reported from an independently conducted study in which the Moderna COVID-19 Vaccine was administered as a second booster dose to 120 participants 18 years of age and older who had received a two-dose primary series and a first booster dose of Pfizer-BioNTech COVID-19 Vaccine at least 4 months prior. No new safety concerns were reported during up to three weeks of follow up after the second booster dose. Immunogenicity data from an ongoing, open-label, non-randomized clinical study in healthcare workers at a single center in Israel were reported in a publication provided to the FDA. In this study, individuals 18 years of age and older who had received primary vaccination and a first booster dose with Pfizer-BioNTech COVID-19 Vaccine were administered a second booster dose of Pfizer-BioNTech COVID-19 Vaccine (154 individuals) or Moderna COVID-19 Vaccine (120 individuals) at least four months after the first booster dose. Among these individuals, increases in neutralizing antibody levels against SARS-CoV-2 virus, including delta and omicron variants were reported two weeks after the second booster as compared to 5 months after the first booster dose. The amendments to the EUAs to include a second booster dose for these populations were granted to Pfizer Inc. and ModernaTX Inc. Additional Resources: Comirnaty and Pfizer-BioNTech COVID-19 Vaccine Spikevax and Moderna COVID-19 Vaccine COVID-19 Vaccines Emergency Use Authorization for Vaccines Explained

Scientists find racial and ethnic disparities in use of pediatric acute asthma care | National Institutes of Health (NIH)

Scientists find racial and ethnic disparities in use of pediatric acute asthma care | National Institutes of Health (NIH)

CAHPS Child Hospital Survey and Guidance | The CAHPS® Database

CAHPS Child Hospital Survey and Guidance | The CAHPS® Database

Association between the COVID-19 pandemic and inflammatory bowel disease presentation in New York City

Association between the COVID-19 pandemic and inflammatory bowel disease presentation in New York City

At a Tennessee crossroads, two pharmacies, a monkey, and millions of pills

At a Tennessee crossroads, two pharmacies, a monkey, and millions of pills

Colorado doubles down on abortion rights as other states — and the high court — reconsider

Colorado doubles down on abortion rights as other states — and the high court — reconsider

Genus Decision Continues to Ripple Through Industry

Genus Decision Continues to Ripple Through Industry

Division of Applied Regulatory Science 2021 Annual Report

Division of Applied Regulatory Science 2021 Annual Report

Projected | CMS

Projected | CMS CMS Office of the Actuary Releases 2021-2030 Projections of National Health Expenditures Report shows slower projected national health spending growth after the rapid 2020 growth associated with the COVID-19 pandemic Today, the Centers for Medicare & Medicaid Services (CMS) released the 2021-2030 National Health Expenditure (NHE) report, prepared by the CMS Office of the Actuary, that presents health spending and enrollment projections for the coming decade. The report notably shows that despite the increased demand for patient care in 2021, the growth in national health spending is estimated to have slowed to 4.2%, from 9.7% in 2020, as supplemental funding for public health activity and other federal programs, specifically those associated with the COVID-19 pandemic, declined significantly. The NHE has been published annually since 1960, and is often referred to as the “official” estimates of U.S. health spending. The historical and projected estimates of NHE measure total annual U.S. spending for the delivery of health care goods and services by type of good or service (hospital, physician, prescription drugs, etc.), type of payer (private health insurance, Medicare, Medicaid, etc.), and type of sponsor (businesses, households and federal/state governments). The NHE report also includes spending on government public health, investment in structures and equipment, and noncommercial research, as well as information on insurance enrollment and uninsured estimates. The report finds that annual growth in national health spending is expected to average 5.1% over 2021-2030, and to reach nearly $6.8 trillion by 2030. Growth in the nation’s Gross Domestic Product (GDP) is also projected to be 5.1% annually over the same period. As a result of the comparable projected rates of growth, the health share of GDP is expected to be 19.6% in 2030, nearly the same as the 2020 share of 19.7%. Near-term expected trends in health spending and insurance enrollments are significantly influenced by the COVID-19 public health emergency (PHE). In 2021, spending for other federal programs and public health activity (the NHE Accounts categories that include the federal COVID-19 supplemental funding) is expected to have declined from $417.6 billion in 2020 to $286.8 billion. Additionally, following the declines observed in 2020, health care utilization is expected to rebound starting in 2021 and then normalize through 2024. As COVID-19 federal supplemental funding is expected to wane between 2021 and 2024, the government’s share of national health spending is expected to fall to 46% by 2024, down from an all-time high of 51% in 2020. The average annual growth in national health spending over the latter half of the next decade (2025-2030) is projected to be 5.3% and is expected to be driven primarily by more traditional elements, including economic, demographic, and health-specific factors. During this time, upward pressure on spending growth for Medicaid is expected, in part due to the expiration of Disproportionate Share Hospital payment cap reductions statutorily scheduled to end in 2027. Conversely, downward pressure on spending growth is expected for Medicare (related to the end of the Baby Boomers’ enrollments), as well as for private health insurance and out-of-pocket spending in lagged response to slowing income growth earlier in the period. The percentage of the population with health insurance is expected to be 91.1% in 2021 and 2022 (mainly due to gains in Medicaid enrollment that are, in large part, due to special rules in effect only during the COVID-19 PHE). After the end of the COVID-19 PHE, enrollments are projected to begin returning to pre-pandemic distributions. The 2030 insured rate is projected to be 89.8%. Selected highlights in national health expenditures by major payer include: Medicare: Medicare spending growth is projected to average 7.2% over 2021-2030, the fastest rate among the major payers. Projected spending growth of 11.3% in 2021 is expected to be mainly influenced by an assumed acceleration in utilization growth, while growth in 2022 of 7.5% is expected to reflect more moderate growth in use, as well as lower fee-for-service payment rate updates and the phasing in of sequestration cuts. Spending is projected to exceed $1 trillion for the first time in 2023. By 2030, Medicare spending growth is expected to slow to 4.3% as the Baby Boomers are no longer enrolling and as further increases in sequestration cuts occur. Medicaid: Average annual growth of 5.6% is projected for Medicaid spending for 2021-2030. Medicaid spending growth is expected to have accelerated to 10.4% in 2021, associated with rapid gains in enrollment. Over 2022 and 2023, Medicaid spending growth is expected to slow to 5.7% and 2.7%, respectively, as a result of projected enrollment declines, after the end of the COVID-19 PHE, when the continuous enrollment condition under the Families First Coronavirus Response Act expires and states begin to disenroll beneficiaries no longer eligible for Medicaid. Over 2025-2030, spending growth is projected to increase an average 5.6%, in part due to the expiration of Disproportionate Share Hospital payment cap reductions set for late-2027. Spending is projected to exceed $1 trillion for the first time in 2028. Private Health Insurance and Out-of-Pocket: For 2021-2030, private health insurance spending growth is projected to average 5.7%. A rebound in utilization is expected to primarily influence private health insurance spending growth over 2021 (6.3%) and 2022 (8.3%), and then normalize through 2024. Over 2025-2030, as health spending trends by private payers tend to be influenced on a lagged basis by changes in income growth, average growth for private health insurance spending is then expected to slow to 4.8% by 2030 in response to slowing income growth earlier in the projection period. Out-of-pocket expenditures are projected to grow at an average rate of 4.6% over 2021-2030 and to represent 9% of total spending by 2030 (ultimately falling from its current historic low of 9.4% in 2020). Selected highlights in projected health expenditures for the three largest goods and services categories are as follows: Hospital: Hospital spending growth is projected to average 5.7% for 2021-2030. In 2021, hospital spending growth is expected to be 5.7%, a deceleration from 6.4% in 2020, largely due to declining federal supplemental payments. However, growth in hospital spending for Medicare, Medicaid, and private health insurance are expected to have grown faster compared to 2020 due to a partial rebound in utilization. Demand for care is expected to remain elevated in 2022, along with a projected acceleration in price growth; as a result, hospital spending growth is likewise expected to accelerate to 6.9% in 2022. Over 2023 and 2024, growth is expected to normalize (5.6% per year) and transition away from pandemic-related impacts on utilization, federal program funding, and changes in insurance enrollment, and remain similar on average through 2030 (5.5% per year). Key factors influencing hospital spending growth over 2025-30 is faster projected growth in Medicaid spending due to the scheduled expiration of Disproportionate Share Hospital payment cap reductions, as well as slower expected growth in Medicare spending (slower enrollment growth and larger sequestration-based cuts) and private health insurance spending (in lagged response to slowing income growth). Physician and Clinical Services: Physician and clinical services spending is projected to grow an average of 5.6% per year over 2021-2030. In 2021, growth in physician and clinical services spending is expected be 5.1%, which is slower than growth of 5.4% in 2020, mainly due to declines in supplemental funding more than offsetting expected utilization increases among Medicare and private health insurance enrollees. Consumers are expected to return to more typical use patterns in 2022 resulting in 6.2% growth. Pandemic-related effects are expected to diminish through 2024. Through 2030, average total physician and clinical services spending growth of 5.5% is expected to primarily reflect decelerating spending growth for private health insurance enrollees in lagged response to projected slower growth in incomes earlier in the period. Retail Prescription Drugs: Spending growth for retail prescription drugs is projected to increase over 2021-2030 at an average rate of 5%. In 2021, growth is expected to accelerate (4.7%) compared to 2020 (3%) due to faster growth in utilization by Medicaid beneficiaries and those enrolled in private health insurance. In 2022, however, overall retail prescription drug spending growth is projected to slow to 4.3%, as declines in Medicaid enrollment are expected to lead to slower drug spending for that program and more than offset faster Medicare spending for drugs in that year. New drugs expected to be approved from 2021-2026 are expected to influence retail prescription drug spending utilization and prices over the remainder of the projection period; over 2025-2030, retail prescription drug spending growth is anticipated to average 5.2%. The Office of the Actuary’s report will appear at: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NationalHealthAccountsProjected.html An article about the study is also being published by Health Affairs and is available here: https://www.healthaffairs.org/

Global vaccination must be swifter

Global vaccination must be swifter

COVID-19 Noticias / Opiniones CHEQUEADAS EN INGLÉS y otros idiomas

COVID-19 Noticias / Opiniones CHEQUEADAS EN INGLÉS y otros idiomas

Oxford Covid jab gears up for final act: saving the rest of the world | Vaccines and immunisation | The Guardian

Oxford Covid jab gears up for final act: saving the rest of the world | Vaccines and immunisation | The Guardian

Did the COVID lockdowns work? Here's what we know two years on

Did the COVID lockdowns work? Here's what we know two years on

COVID-19 Noticias / Opiniones CHEQUEADAS

COVID-19 Noticias / Opiniones CHEQUEADAS

COVID-19 Noticias / Opiniones CHEQUEADAS - Covid-19 en Francia: aumentan los casos y las hospitalizaciones

COVID-19 Noticias / Opiniones CHEQUEADAS - Covid-19 en Francia: aumentan los casos y las hospitalizaciones

COVID-19 Noticias / Opiniones CHEQUEADAS - Canadá: controversia gubernamental para enfrentar la variante de Ómicron

COVID-19 Noticias / Opiniones CHEQUEADAS - Canadá: controversia gubernamental para enfrentar la variante de Ómicron

Programa Actualización Científica sin Exclusiones (ACisE)

Programa Actualización Científica sin Exclusiones (ACisE)

Indice General de Autoevaluaciones

Indice General de Autoevaluaciones

Novedades COVID-19

Novedades COVID-19

Global Health Matters Newsletter - Fogarty International Center @ NIH

Global Health Matters Newsletter - Fogarty International Center @ NIH

Projects examine sex, behavior differences that impact men’s health - Fogarty International Center @ NIH

Projects examine sex, behavior differences that impact men’s health - Fogarty International Center @ NIH

Fogarty International Center

Fogarty International Center

CDRHNew - News and Updates | FDA

CDRHNew - News and Updates | FDA

What’s New for Biologics | FDA

What’s New for Biologics | FDA

Explained: Why prices of some drugs could see the steepest increase in years | Explained News,The Indian Express

Explained: Why prices of some drugs could see the steepest increase in years | Explained News,The Indian Express

lunes, 28 de marzo de 2022

Violence Against Nurses Escalates; New Measures Seek to Curb

Violence Against Nurses Escalates; New Measures Seek to Curb

Appeals Against Medical Insurance Denials Underused, Says Lawyer

Appeals Against Medical Insurance Denials Underused, Says Lawyer

The Medical Model Doesn't Work for Mental Health

The Medical Model Doesn't Work for Mental Health

New, Simpler Pneumococcal Vaccine Recommendations for 2022

New, Simpler Pneumococcal Vaccine Recommendations for 2022

The patient experience: Uncovering the barriers to care for insured Americans

The patient experience: Uncovering the barriers to care for insured Americans

Which U.S. cities are most vulnerable to spread of COVID-19?

Which U.S. cities are most vulnerable to spread of COVID-19?

Study finds fewer hospital visits for stroke in first year of COVID-19 pandemic

Study finds fewer hospital visits for stroke in first year of COVID-19 pandemic

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Benefits of heterotypic vaccination against variants of SARS-CoV-2

Benefits of heterotypic vaccination against variants of SARS-CoV-2

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

Big pharma is betting on bigger political ambitions from Sen. Tim Scott

Climate change may push the US toward the ‘goldilocks zone’ for West Nile virus

Climate change may push the US toward the ‘goldilocks zone’ for West Nile virus

‘An Arm and a Leg’: A fight for the right to help

‘An Arm and a Leg’: A fight for the right to help

Study estimates protection against reinfection following primary SARS-CoV-2 infection

Study estimates protection against reinfection following primary SARS-CoV-2 infection

The potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients

The potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Notable; The Future of Intelligent Automation in Healthcare

Notable; The Future of Intelligent Automation in Healthcare

Dynamics of SARS-CoV-2 viral load in vaccinated and recovered individuals

Dynamics of SARS-CoV-2 viral load in vaccinated and recovered individuals

CDRHNew - News and Updates | FDA

CDRHNew - News and Updates | FDA

OTC Monograph Reform: Overview of Draft Guidance for Formal Meetings - 03/29/2022 | FDA

OTC Monograph Reform: Overview of Draft Guidance for Formal Meetings - 03/29/2022 | FDA

FDA Grand Rounds | FDA

FDA Grand Rounds | FDA

domingo, 27 de marzo de 2022

Specific PHGKB|Infectious Diseases|PHGKB

Specific PHGKB|<bean:write name="specificPHGKBForm" property="topic" />|PHGKB

Specific PHGKB|Pharmacogenomics PHGKB|PHGKB

Specific PHGKB|Pharmacogenomics PHGKB|PHGKB

Specific PHGKB|Health Equity PHGKB|PHGKB

Specific PHGKB|Health Equity PHGKB|PHGKB

Specific PHGKB|Environmental Health PHGKB|PHGKB

Specific PHGKB|Environmental Health PHGKB|PHGKB

CDC-Authored Publications Update|PHGKB

CDC-Authored Publications Update|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

COVID-19 CDC Publications Database

COVID-19 CDC Publications Database

From Guthrie to Genomes: Expanding Bioinformatic Capabilities in Newborn Screening Programs | Blogs | CDC

From Guthrie to Genomes: Expanding Bioinformatic Capabilities in Newborn Screening Programs | Blogs | CDC

Advancing Implementation Science in Precision Public Health: Ensuring Health Equity and Balancing Evolution and Sustainment | CDC

Advancing Implementation Science in Precision Public Health: Ensuring Health Equity and Balancing Evolution and Sustainment | CDC

COVID-19 GPH|Home|PHGKB

COVID-19 GPH|Home|PHGKB

How new data from the All of Us Research Program will help address the diversity problem in genomics L Eisenstadt, Broad Institute, March 2022

Main|Search|PHGKB

Genomics and Precision Health Topics | CDC

Genomics and Precision Health Topics | CDC

Study examines how facts and fake news on social media influence COVID-19 vaccine uptake

Study examines how facts and fake news on social media influence COVID-19 vaccine uptake

Countries in Europe, Asia see surge in Covid-19 cases; some Chinese cities enter lockdown | World News,The Indian Express

Countries in Europe, Asia see surge in Covid-19 cases; some Chinese cities enter lockdown | World News,The Indian Express

sábado, 26 de marzo de 2022

Vaccines and Related Biological Products Advisory Committee Meeting April 6, 2022 Announcement - 04/06/2022 | FDA

Vaccines and Related Biological Products Advisory Committee Meeting April 6, 2022 Announcement - 04/06/2022 | FDA

Infection Prevention and Control for the Emergency Medical Services/911 Workforce | Effective Health Care (EHC) Program

Infection Prevention and Control for the Emergency Medical Services/911 Workforce | Effective Health Care (EHC) Program

Dra. Marisa Aizenberg: El metaverso y nuestra salud mental

Dra. Marisa Aizenberg: El metaverso y nuestra salud mental

Outdoor mass gathering events and SARS-CoV-2 infection in Catalonia (North-East Spain) - The Lancet Regional Health – Europe

Outdoor mass gathering events and SARS-CoV-2 infection in Catalonia (North-East Spain) - The Lancet Regional Health – Europe

Racial and socioeconomic status differences in stress, posttraumatic growth, and mental health in an older adult cohort during the COVID-19 pandemic - eClinicalMedicine

Racial and socioeconomic status differences in stress, posttraumatic growth, and mental health in an older adult cohort during the COVID-19 pandemic - eClinicalMedicine

Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum - eClinicalMedicine

Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum - eClinicalMedicine

Healthcare workers’ views on mandatory SARS-CoV-2 vaccination in the UK: A cross-sectional, mixed-methods analysis from the UK-REACH study - eClinicalMedicine

Healthcare workers’ views on mandatory SARS-CoV-2 vaccination in the UK: A cross-sectional, mixed-methods analysis from the UK-REACH study - eClinicalMedicine

Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all? - eBioMedicine

Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all? - eBioMedicine

Mind the gap – Managing tuberculosis across the disease spectrum - eBioMedicine

Mind the gap – Managing tuberculosis across the disease spectrum - eBioMedicine

The crucial need for tuberculosis translational research in the time of COVID-19 - The Lancet Respiratory Medicine

The crucial need for tuberculosis translational research in the time of COVID-19 - The Lancet Respiratory Medicine

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? - The Lancet Respiratory Medicine

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? - The Lancet Respiratory Medicine

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions - The Lancet Respiratory Medicine

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions - The Lancet Respiratory Medicine

Can COVID-19 changes reduce stigma in African HIV clinics? - The Lancet HIV

Can COVID-19 changes reduce stigma in African HIV clinics? - The Lancet HIV

Assessing the effectiveness of COVID-19 vaccines in older people in Latin America - The Lancet Healthy Longevity

Assessing the effectiveness of COVID-19 vaccines in older people in Latin America - The Lancet Healthy Longevity

Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohort - The Lancet Healthy Longevity

Effectiveness of COVID-19 vaccines in older adults in Colombia: a retrospective, population-based study of the ESPERANZA cohort - The Lancet Healthy Longevity

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study - The Lancet Digital Health

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study - The Lancet Digital Health

Strengthening public mental health during and after the acute phase of the COVID-19 pandemic - The Lancet

Strengthening public mental health during and after the acute phase of the COVID-19 pandemic - The Lancet

Sisonke: reaching several goals together - The Lancet

Sisonke: reaching several goals together - The Lancet

viernes, 25 de marzo de 2022

With UV Light, N95 Masks Can Be Cleaned and Reused Safely

Ultraviolet Light Can Clean N95 Masks for Reuse Without Hindering Performance, NIST Study Shows | NIST

Ultraviolet Light Can Clean N95 Masks for Reuse Without Hindering Performance, NIST Study Shows | NIST

NIH Funding for Pragmatic and Implementation Trials of Embedded Interventions: Join the April 5 Technical Assistance Webinar | NCCIH

NIH Funding for Pragmatic and Implementation Trials of Embedded Interventions: Join the April 5 Technical Assistance Webinar | NCCIH

Back-to-the-Office Blues? Here's Some Help

Back-to-the-Office Blues? Here's Some Help

I Don't Have a Patient Portal. And I Probably Never Will

I Don't Have a Patient Portal. And I Probably Never Will

Going Virtual, Both in Class and the Clinic

Going Virtual, Both in Class and the Clinic

Journal of Pharmaceutical Health Care and Sciences | Home page

Journal of Pharmaceutical Health Care and Sciences | Home page

Health Economics Review | Home page

Health Economics Review | Home page

Health Research Policy and Systems | Home page

Health Research Policy and Systems | Home page

Human Resources for Health | Home page

Human Resources for Health | Home page

Implementation Science Communications | Home implementationsciencecomms.Biomedcentral.Com

Implementation Science Communications | Home implementationsciencecomms.Biomedcentral.Com

Infectious Diseases of Poverty | Home page

Infectious Diseases of Poverty | Home page

Vaccination and covid-19

Vaccination and covid-19

Israel Journal of Health Policy Research | Home page

Israel Journal of Health Policy Research | Home page

Substance Abuse Treatment, Prevention, and Policy | Home page

Substance Abuse Treatment, Prevention, and Policy | Home page

Journal of Pharmaceutical Policy and Practice | Home page

Journal of Pharmaceutical Policy and Practice | Home page

BMC Medical Ethics | Home page

BMC Medical Ethics | Home page

An Acceptable Circular of Information for the Use of Human Blood and Blood Components | FDA

An Acceptable Circular of Information for the Use of Human Blood and Blood Components | FDA

CDRHNew - News and Updates | FDA

CDRHNew - News and Updates | FDA

Spotlight: Pandemic Underscores Value of Telehealth Options for AUD Treatment | NIAAA Spectrum | NIAAA Spectrum

Spotlight: Pandemic Underscores Value of Telehealth Options for AUD Treatment | NIAAA Spectrum | NIAAA Spectrum

NYC Lifts Vaccine Rule That Blocked Athletes From Home Games

NYC Lifts Vaccine Rule That Blocked Athletes From Home Games

Judge Sides With 12 Disabled Kids Seeking Masks in Schools

Judge Sides With 12 Disabled Kids Seeking Masks in Schools

Idaho Governor Signs 6-Week Abortion Ban Bill

Idaho Governor Signs 6-Week Abortion Ban Bill

Subsidized COVID Testing, Treatments, and Vaccines May End Soon

Subsidized COVID Testing, Treatments, and Vaccines May End Soon

Generic Drugs Forum 2022: The Current State of Generic Drugs - 04/26/2022 | FDA

Generic Drugs Forum 2022: The Current State of Generic Drugs - 04/26/2022 | FDA

Improving Nutrition to Turn the Tide on Diet-Related Chronic Disease | FDA

Improving Nutrition to Turn the Tide on Diet-Related Chronic Disease | FDA

What’s New for Biologics | FDA

What’s New for Biologics | FDA

jueves, 24 de marzo de 2022

Cytobank platform from Beckman Coulter Life Sciences

Cytobank platform from Beckman Coulter Life Sciences

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Antidopaminergic antiemetics associated with elevated risk of ischemic stroke

Antidopaminergic antiemetics associated with elevated risk of ischemic stroke

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

New SARS-CoV-2 Omicron-Delta recombinant virus identified in the US

New SARS-CoV-2 Omicron-Delta recombinant virus identified in the US

Programmable button technology reduces the time for heart attack diagnosis

Programmable button technology reduces the time for heart attack diagnosis

The Ecosystem Behind Innovative Vaccine Approaches| Innovation.org

The Ecosystem Behind Innovative Vaccine Approaches| Innovation.org

Guest Post: If we truly want to cure complex diseases, politicians should reject price setting

Guest Post: If we truly want to cure complex diseases, politicians should reject price setting

The accelerated approval pathway: Helping patients with serious or life-threatening diseases

The accelerated approval pathway: Helping patients with serious or life-threatening diseases

Biopharmaceutical industry drives economic growth in all 50 states

Biopharmaceutical industry drives economic growth in all 50 states

2022-03-24-MLNC | CMS

2022-03-24-MLNC | CMS

Tuberculosis in the time of COVID-19

Tuberculosis in the time of COVID-19

eBioMedicine

eBioMedicine

The Lancet Respiratory Medicine

The Lancet Respiratory Medicine

Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all? - eBioMedicine

Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all? - eBioMedicine

Mind the gap – Managing tuberculosis across the disease spectrum - eBioMedicine

Mind the gap – Managing tuberculosis across the disease spectrum - eBioMedicine

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions - The Lancet Respiratory Medicine

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions - The Lancet Respiratory Medicine

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions - The Lancet Respiratory Medicine

The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions - The Lancet Respiratory Medicine

Supporting families with tuberculosis during COVID-19 in Khayelithsa, South Africa - The Lancet Respiratory Medicine

Supporting families with tuberculosis during COVID-19 in Khayelithsa, South Africa - The Lancet Respiratory Medicine

The crucial need for tuberculosis translational research in the time of COVID-19 - The Lancet Respiratory Medicine

The crucial need for tuberculosis translational research in the time of COVID-19 - The Lancet Respiratory Medicine

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? - The Lancet Respiratory Medicine

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? - The Lancet Respiratory Medicine

Error reduction in trauma care: Lessons from an anonymized, national, multicenter mortality reporting system. | PSNet

Error reduction in trauma care: Lessons from an anonymized, national, multicenter mortality reporting system. | PSNet

Association between operative autonomy of surgical residents and patient outcomes. | PSNet

Association between operative autonomy of surgical residents and patient outcomes. | PSNet

Patient harm and institutional avoidability of out-of-hours discharge from intensive care: an analysis using mixed methods. | PSNet

Patient harm and institutional avoidability of out-of-hours discharge from intensive care: an analysis using mixed methods. | PSNet

Fighting TB with lessons learnt during Covid pandemic | The Indian Express

Fighting TB with lessons learnt during Covid pandemic | The Indian Express

Explained: Covid cases falling, disaster Act revoked — how will your life change after March 31? | Explained News,The Indian Express

Explained: Covid cases falling, disaster Act revoked — how will your life change after March 31? | Explained News,The Indian Express

Cancer Moonshot Seminar Series - National Cancer Institute

Cancer Moonshot Seminar Series - National Cancer Institute

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters | FDA

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters | FDA

COVID-19 Vaccines | FDA

COVID-19 Vaccines | FDA

health-insurance-exchanges-2022-open-enrollment-report-final.pdf

health-insurance-exchanges-2022-open-enrollment-report-final.pdf

Program Releases | Medicaid.gov

Program Releases | Medicaid.gov

Save the Dates: Upcoming Spring 2022 HCUP Trainings!

Save the Dates: Upcoming Spring 2022 HCUP Trainings!

DERECHO Y SALUD: PROCEDE PROVEER A LA BENEFICIARIA DE UNA MEDICACIÓN DE CARÁCTER EXPERIMENTAL NO APROBADA POR ANMAT

DERECHO Y SALUD: PROCEDE PROVEER A LA BENEFICIARIA DE UNA MEDICACIÓN DE CARÁCTER EXPERIMENTAL NO APROBADA POR ANMAT

miércoles, 23 de marzo de 2022

Israelis crowdfund rescue for elderly, disabled in Ukraine - ISRAEL21c

Israelis crowdfund rescue for elderly, disabled in Ukraine - ISRAEL21c

Magen David Adom sends armored ambulances to Ukraine - ISRAEL21c

Magen David Adom sends armored ambulances to Ukraine - ISRAEL21c

Israel opens humanitarian field hospital in war-torn Ukraine - ISRAEL21c

Israel opens humanitarian field hospital in war-torn Ukraine - ISRAEL21c

How has the COVID-19 Pandemic Impacted the Adoption of Digital Health Technology?

How has the COVID-19 Pandemic Impacted the Adoption of Digital Health Technology?

NUEVA REGLAMENTACIÓN DE FARMACIAS HOSPITALARIAS

NUEVA REGLAMENTACIÓN DE FARMACIAS HOSPITALARIAS

CDRHNew - News and Updates | FDA

CDRHNew - News and Updates | FDA

Surgeon burnout, impact on patient safety and professionalism: a systematic review and meta-analysis. | PSNet

Surgeon burnout, impact on patient safety and professionalism: a systematic review and meta-analysis. | PSNet

Drug-related deaths among inpatients: a meta-analysis. | PSNet

Drug-related deaths among inpatients: a meta-analysis. | PSNet

Estimation of breast cancer overdiagnosis in a U.S. breast screening cohort. | PSNet

Estimation of breast cancer overdiagnosis in a U.S. breast screening cohort. | PSNet

Improving the specificity of drug-drug interaction alerts: Can it be done? - PubMed

Improving the specificity of drug-drug interaction alerts: Can it be done? - PubMed

AHRQ Impact Case Studies | Agency for Healthcare Research and Quality

AHRQ Impact Case Studies | Agency for Healthcare Research and Quality

Patient-Centered Outcomes Research (PCOR) at AHRQ | Agency for Healthcare Research and Quality

Patient-Centered Outcomes Research (PCOR) at AHRQ | Agency for Healthcare Research and Quality

AHRQ’s Patient-Centered Outcomes Research Strategic Framework: Request for Public Comment | Agency for Healthcare Research and Quality

AHRQ’s Patient-Centered Outcomes Research Strategic Framework: Request for Public Comment | Agency for Healthcare Research and Quality

Potential of the Patient-Centered Outcomes Research Trust Fund | Agency for Healthcare Research and Quality

Potential of the Patient-Centered Outcomes Research Trust Fund | Agency for Healthcare Research and Quality

Federal Register :: Request for Information: AHRQ's Proposed Patient-Centered Outcomes Research Trust Fund Strategic Framework

Federal Register :: Request for Information: AHRQ's Proposed Patient-Centered Outcomes Research Trust Fund Strategic Framework

Tobacco Surcharges Associated With Reduced ACA Marketplace Enrollment - PubMed

Tobacco Surcharges Associated With Reduced ACA Marketplace Enrollment - PubMed

Changes in Outpatient Opioid Prescribing During the COVID-19 Pandemic: An Interrupted Time Series Analysis - PubMed

Changes in Outpatient Opioid Prescribing During the COVID-19 Pandemic: An Interrupted Time Series Analysis - PubMed

Variation in Bacterial Respiratory Culture Results in Children With Neurologic Impairment - PubMed

Variation in Bacterial Respiratory Culture Results in Children With Neurologic Impairment - PubMed

Toolkit for Decolonization of Non-ICU Patients With Devices | Agency for Healthcare Research and Quality

Toolkit for Decolonization of Non-ICU Patients With Devices | Agency for Healthcare Research and Quality

Development of a Symptom-Focused Model to Guide the Prescribing of Antipsychotics in Children and Adolescents: Results of the First Phase of the Safer Use of Antipsychotics in Youth (SUAY) Clinical Trial - PubMed

Development of a Symptom-Focused Model to Guide the Prescribing of Antipsychotics in Children and Adolescents: Results of the First Phase of the Safer Use of Antipsychotics in Youth (SUAY) Clinical Trial - PubMed

Association of Socioeconomic Characteristics With Where Children Receive Emergency Care - PubMed

Association of Socioeconomic Characteristics With Where Children Receive Emergency Care - PubMed

Physician Risk Perception and Testing Behaviors for Children With Fever - PubMed

Physician Risk Perception and Testing Behaviors for Children With Fever - PubMed

Association of Elementary School Reopening Status and County COVID-19 Incidence - PubMed

Association of Elementary School Reopening Status and County COVID-19 Incidence - PubMed

Data Infographics | Agency for Healthcare Research and Quality

Data Infographics | Agency for Healthcare Research and Quality

STATISTICAL BRIEF #539: Healthcare Expenditures for Treatment of Mental Disorders: Estimates for Adults Ages 18 and Older, U.S. Civilian Noninstitutionalized Population, 2019

STATISTICAL BRIEF #539: Healthcare Expenditures for Treatment of Mental Disorders: Estimates for Adults Ages 18 and Older, U.S. Civilian Noninstitutionalized Population, 2019

Cost Analysis of an Annual School-Based Pediatric Hearing Screening Program in Semi-Rural Kenya - PubMed

Cost Analysis of an Annual School-Based Pediatric Hearing Screening Program in Semi-Rural Kenya - PubMed

Adolescents with Vulvar Ulcers: COVID-19 disease, COVID-19 Vaccines, and the Value of Case Reports - PubMed

Adolescents with Vulvar Ulcers: COVID-19 disease, COVID-19 Vaccines, and the Value of Case Reports - PubMed

Dra. Marisa Aizenberg: Metaverso y Salud: Aimedis Health City, el primer complejo médico instalado en un metaverso

Dra. Marisa Aizenberg: Metaverso y Salud: Aimedis Health City, el primer complejo médico instalado en un metaverso

PUBL352.PS

PUBL352.PS

Immunogenicity Information in Labeling - 04/05/2022 | FDA

Immunogenicity Information in Labeling - 04/05/2022 | FDA

Registration for March 2022 Virtual Meeting for the AHRQ Software Developers Meeting - Common Formats

Registration for March 2022 Virtual Meeting for the AHRQ Software Developers Meeting - Common Formats Join Patient Safety Organization Representatives for a March 31 Virtual Meeting on AHRQ’s Common Formats Software developers, vendors, and other users interested in improving ways to collect and analyze patient safety data using AHRQ’s Common Formats are invited to join a free virtual meeting on Thursday, March 31 from 1 to 2:30 PM ET. Representatives from two Patient Safety Organizations that currently use Common Formats in their work with healthcare providers will share their experiences and challenges. Register by Wednesday, March 30: https://cma.ahrq.gov/cma/registration.jsp?eventid=157

Collaboration and Shared Decision-Making Between Patients and Clinicians in Preventive Health Care Decisions and US Preventive Services Task Force Recommendations | Guidelines | JAMA | JAMA Network

Collaboration and Shared Decision-Making Between Patients and Clinicians in Preventive Health Care Decisions and US Preventive Services Task Force Recommendations | Guidelines | JAMA | JAMA Network

Medical Device User Fee Amendments 2023 (MDUFA V) | FDA

Medical Device User Fee Amendments 2023 (MDUFA V) | FDA

FDA Investigation of Cronobacter Infections: Powdered Infant Formula (February 2022) | FDA

FDA Investigation of Cronobacter Infections: Powdered Infant Formula (February 2022) | FDA

What’s New for Biologics | FDA

What’s New for Biologics | FDA

Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4 Guidance for Industry | FDA

Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4 Guidance for Industry | FDA

martes, 22 de marzo de 2022

Federal Register :: Prioritizing the Addition of Maximum Daily Exposure Information and Removing Dosage Form Information From the Inactive Ingredient Database; Establishment of a Public Docket; Request for Comments

Federal Register :: Prioritizing the Addition of Maximum Daily Exposure Information and Removing Dosage Form Information From the Inactive Ingredient Database; Establishment of a Public Docket; Request for Comments

Doctors Finding Hurdles to Using Pills to Treat COVID-19

Doctors Finding Hurdles to Using Pills to Treat COVID-19

Trial Gives New Guidance for Choosing Initial PsA Treatment

Trial Gives New Guidance for Choosing Initial PsA Treatment

Health Officials Urge Preparation, Not Panic, for Next COVID Wave

Health Officials Urge Preparation, Not Panic, for Next COVID Wave

CDRHNew - News and Updates | FDA

CDRHNew - News and Updates | FDA

New AHRQ Toolkit Helps Prevent Infection in Non-ICU Hospital Patients with Devices

New AHRQ Toolkit Helps Prevent Infection in Non-ICU Hospital Patients with Devices

NCI-led collaboration aims to improve diagnoses for childhood cancers - National Cancer Institute

NCI-led collaboration aims to improve diagnoses for childhood cancers - National Cancer Institute

How to Apply for a Scholarship | NHSC

How to Apply for a Scholarship | NHSC

COVID-19 Noticias / Opiniones CHEQUEADAS EN INGLÉS y otros idiomas

COVID-19 Noticias / Opiniones CHEQUEADAS EN INGLÉS y otros idiomas

COVID-19 Noticias / Opiniones CHEQUEADAS

COVID-19 Noticias / Opiniones CHEQUEADAS

COVID-19 Noticias / Opiniones CHEQUEADAS - Alemania alcanza la mayor tasa de Covid-19 desde el comienzo de la pandemia

COVID-19 Noticias / Opiniones CHEQUEADAS - Alemania alcanza la mayor tasa de Covid-19 desde el comienzo de la pandemia

COVID-19 Noticias / Opiniones CHEQUEADAS - Corea del Sur: la variante Ómicron eleva a 550 mil casos los contagios de un solo día

COVID-19 Noticias / Opiniones CHEQUEADAS - Corea del Sur: la variante Ómicron eleva a 550 mil casos los contagios de un solo día

COVID-19 Noticias / Opiniones CHEQUEADAS - Uruguay: la variante BA.2 desplazaría a Ómicron en los próximos meses

COVID-19 Noticias / Opiniones CHEQUEADAS - Uruguay: la variante BA.2 desplazaría a Ómicron en los próximos meses

COVID-19 Noticias / Opiniones CHEQUEADAS - La exitosa experiencia vacunatoria de la Argentina

COVID-19 Noticias / Opiniones CHEQUEADAS - La exitosa experiencia vacunatoria de la Argentina

COVID-19 ESPECIALISTAS opinan Expertos Invitados (Castellano)

COVID-19 ESPECIALISTAS opinan Expertos Invitados (Castellano)

Indice General de Autoevaluaciones

Indice General de Autoevaluaciones

COVID-19 Informes Científicos CHEQUEADOS COMPLETOS REVISADOS (full texts)

COVID-19 Informes Científicos CHEQUEADOS COMPLETOS REVISADOS (full texts)

Caring for older adults during the COVID-19 pandemic - Clinical Microbiology and Infection

Caring for older adults during the COVID-19 pandemic - Clinical Microbiology and Infection

Novedades COVID-19

Novedades COVID-19

What’s New for Biologics | FDA

What’s New for Biologics | FDA

The Impact of Interventions to Prevent Neonatal Healthcare-associated Infections in Low- and Middle-income Countries: A Systematic Review - PubMed

The Impact of Interventions to Prevent Neonatal Healthcare-associated Infections in Low- and Middle-income Countries: A Systematic Review - PubMed

Fogarty International Center

Fogarty International Center

Spatio-temporal modelling of malaria mortality in India from 2004 to 2013 from the Million Death Study - PubMed

Spatio-temporal modelling of malaria mortality in India from 2004 to 2013 from the Million Death Study - PubMed

Men’s health often neglected in global health research - Fogarty International Center @ NIH

Men’s health often neglected in global health research - Fogarty International Center @ NIH

FDA approves pembrolizumab for advanced endometrial carcinoma | FDA

FDA approves pembrolizumab for advanced endometrial carcinoma | FDA

Toolkit for Decolonization of Non-ICU Patients With Devices | Agency for Healthcare Research and Quality

Toolkit for Decolonization of Non-ICU Patients With Devices | Agency for Healthcare Research and Quality

lunes, 21 de marzo de 2022

Dra. Marisa Aizenberg: Cómo se aplicará el metaverso en el trabajo

Dra. Marisa Aizenberg: Cómo se aplicará el metaverso en el trabajo

Mitigating the effects of gender bias in clinical trials - ISRAEL21c

Mitigating the effects of gender bias in clinical trials - ISRAEL21c

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters | FDA

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters | FDA

Data Leakage Due to Care Provided Outside of the Study Electronic Health Record System: Potential Biases and Solutions | Sentinel Initiative

Data Leakage Due to Care Provided Outside of the Study Electronic Health Record System: Potential Biases and Solutions | Sentinel Initiative

Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs | ASPE

Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs | ASPE

Innovative Data Science to Identify High-Risk Suicide Populations Webinar1 Tickets, Thu, Apr 28, 2022 at 11:00 AM | Eventbrite

Innovative Data Science to Identify High-Risk Suicide Populations Webinar1 Tickets, Thu, Apr 28, 2022 at 11:00 AM | Eventbrite

FDA approves Opdualag for unresectable or metastatic melanoma | FDA

FDA approves Opdualag for unresectable or metastatic melanoma | FDA

CDRHNew - News and Updates | FDA

CDRHNew - News and Updates | FDA

Moderna, Pfizer Want FDA to OK Second Boosters

Moderna, Pfizer Want FDA to OK Second Boosters

Waiting for the Under-5 COVID-19 Vaccine

Waiting for the Under-5 COVID-19 Vaccine

Physician Burnout & Depression Report 2022: Stress, Anxiety, and Anger

Physician Burnout & Depression Report 2022: Stress, Anxiety, and Anger

Making Prevention a Priority During National Drugs and Alcohol Facts Week | SAMHSA

Making Prevention a Priority During National Drugs and Alcohol Facts Week | SAMHSA

Utilizing Next-Generation Digital Health Technology to Improve Care for People with SMI

Utilizing Next-Generation Digital Health Technology to Improve Care for People with SMI

CLAS Series Part 2: Serving Transgenderd population/Gender Non-Conforming Individuals | Addiction Technology Transfer Center (ATTC) Network

CLAS Series Part 2: Serving Transgenderd population/Gender Non-Conforming Individuals | Addiction Technology Transfer Center (ATTC) Network

Medicaid and School Mental Health 101: How Can Schools Finance School Mental Health Services through Medicaid? | Mental Health Technology Transfer Center (MHTTC) Network

Medicaid and School Mental Health 101: How Can Schools Finance School Mental Health Services through Medicaid? | Mental Health Technology Transfer Center (MHTTC) Network

Family Based Therapy in the Treatment of Adolescent Eating Disorders - What Parents Need to Know | Mental Health Technology Transfer Center (MHTTC) Network

Family Based Therapy in the Treatment of Adolescent Eating Disorders - What Parents Need to Know | Mental Health Technology Transfer Center (MHTTC) Network

Closing Pandora’s Box: Applying Opioid Stewardship to Promote Safe Storage, Handling, and Disposal Practices - PCSS

Closing Pandora’s Box: Applying Opioid Stewardship to Promote Safe Storage, Handling, and Disposal Practices - PCSS

Trauma-Informed Practices | Mental Health Technology Transfer Center (MHTTC) Network

Trauma-Informed Practices | Mental Health Technology Transfer Center (MHTTC) Network

Latino Culture and Communication: More than Just Translation | Addiction Technology Transfer Center (ATTC) Network

Latino Culture and Communication: More than Just Translation | Addiction Technology Transfer Center (ATTC) Network

Gambling in America: Findings from the 2021 NGAGE Survey (HHS Region 1) in Recognition of Problem Gambling Awareness Month | Prevention Technology Transfer Center (PTTC) Network

Gambling in America: Findings from the 2021 NGAGE Survey (HHS Region 1) in Recognition of Problem Gambling Awareness Month | Prevention Technology Transfer Center (PTTC) Network

HIV Prevention in Patients with Substance Use Disorder - PCSS

HIV Prevention in Patients with Substance Use Disorder - PCSS

Understanding Organizational Implicit Bias and its Impact on BIPOC Populations | Mental Health Technology Transfer Center (MHTTC) Network

Understanding Organizational Implicit Bias and its Impact on BIPOC Populations | Mental Health Technology Transfer Center (MHTTC) Network

SOPS Surveys | Agency for Healthcare Research and Quality

SOPS Surveys | Agency for Healthcare Research and Quality

Surveys on Patient Safety Culture (SOPS®) Medical Office Survey: 2022 User Database Report Part I

Surveys on Patient Safety Culture (SOPS®) Medical Office Survey: 2022 User Database Report Part I

NOT-HS-21-014: Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Advance Health Equity

NOT-HS-21-014: Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Advance Health Equity

Overdiagnosis of urinary tract infections by nursing home clinicians versus a clinical guideline - PubMed

Overdiagnosis of urinary tract infections by nursing home clinicians versus a clinical guideline - PubMed

Diagnostic error experiences of patients and families with limited English-language health literacy or disadvantaged socioeconomic position in a cross-sectional US population-based survey - PubMed

Diagnostic error experiences of patients and families with limited English-language health literacy or disadvantaged socioeconomic position in a cross-sectional US population-based survey - PubMed

Improving Education—A Key to Better Diagnostic Outcomes | Agency for Healthcare Research and Quality

Improving Education—A Key to Better Diagnostic Outcomes | Agency for Healthcare Research and Quality

Toolkit to Engage High-Risk Patients In Safe Transitions Across Ambulatory Settings | Agency for Healthcare Research and Quality

Toolkit to Engage High-Risk Patients In Safe Transitions Across Ambulatory Settings | Agency for Healthcare Research and Quality

Guide to Improving Patient Safety in Primary Care Settings by Engaging Patients and Families | Agency for Healthcare Research and Quality

Guide to Improving Patient Safety in Primary Care Settings by Engaging Patients and Families | Agency for Healthcare Research and Quality

Guide to Patient and Family Engagement in Hospital Quality and Safety | Agency for Healthcare Research and Quality

Guide to Patient and Family Engagement in Hospital Quality and Safety | Agency for Healthcare Research and Quality

Toolkit To Improve Antibiotic Use in Long-Term Care | Agency for Healthcare Research and Quality

Toolkit To Improve Antibiotic Use in Long-Term Care | Agency for Healthcare Research and Quality

Toolkit for Engaging Patients To Improve Diagnostic Safety  | Agency for Healthcare Research and Quality

Toolkit for Engaging Patients To Improve Diagnostic Safety  | Agency for Healthcare Research and Quality

Explained: How Covid affects the heart | Explained News,The Indian Express

Explained: How Covid affects the heart | Explained News,The Indian Express

New health law draft: four-tier system, clearly defined powers | India News,The Indian Express

New health law draft: four-tier system, clearly defined powers | India News,The Indian Express

Are You Recall Ready? FDA Expects You to Be

Are You Recall Ready? FDA Expects You to Be

domingo, 20 de marzo de 2022

Specific PHGKB|Pharmacogenomics PHGKB|PHGKB

Specific PHGKB|Pharmacogenomics PHGKB|PHGKB

Specific PHGKB|Health Equity PHGKB|PHGKB

Specific PHGKB|Health Equity PHGKB|PHGKB

CDC-Authored Publications Update|PHGKB

CDC-Authored Publications Update|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

Implementing_Precision_and_Equitable_Public_Health_in_Cascade_Testing_for_Genetic_Disorders

Implementing_Precision_and_Equitable_Public_Health_in_Cascade_Testing_for_Genetic_Disorders

Assessing Pharmacogenetic Variation in the United States to Enhance Health Equity of Pharmacogenetic Testing | Blogs | CDC

Assessing Pharmacogenetic Variation in the United States to Enhance Health Equity of Pharmacogenetic Testing | Blogs | CDC

Racial/Ethnic Disparities in Healthcare Worker Experiences During the COVID-19 Pandemic: An Analysis of the HERO Registry - eClinicalMedicine

Racial/Ethnic Disparities in Healthcare Worker Experiences During the COVID-19 Pandemic: An Analysis of the HERO Registry - eClinicalMedicine

Variation in global COVID-19 symptoms by geography and by chronic disease: A global survey using the COVID-19 Symptom Mapper - eClinicalMedicine

Variation in global COVID-19 symptoms by geography and by chronic disease: A global survey using the COVID-19 Symptom Mapper - eClinicalMedicine

Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study - The Lancet Public Health

Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study - The Lancet Public Health

SARS-CoV-2 transmission: time to rethink public health strategy - The Lancet Infectious Diseases

SARS-CoV-2 transmission: time to rethink public health strategy - The Lancet Infectious Diseases

SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020–21 - The Lancet Infectious Diseases

SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020–21 - The Lancet Infectious Diseases

Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study - The Lancet Infectious Diseases

Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study - The Lancet Infectious Diseases

COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness - The Lancet Global Health

COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness - The Lancet Global Health

A roadmap of recovery for the COVID generation - The Lancet Child & Adolescent Health

A roadmap of recovery for the COVID generation - The Lancet Child & Adolescent Health

Omicron: fewer adverse outcomes come with new dangers - The Lancet

Omicron: fewer adverse outcomes come with new dangers - The Lancet

Evaluating COVID-19 vaccines in the real world - The Lancet

Evaluating COVID-19 vaccines in the real world - The Lancet

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study - The Lancet

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study - The Lancet

viernes, 18 de marzo de 2022

COVID-19-related hospitalization among infants and young children in the US

COVID-19-related hospitalization among infants and young children in the US

Developing a robotic platform to improve the quality of sleep

Developing a robotic platform to improve the quality of sleep

World Sleep Day: Diagnosing chronic respiratory diseases from within the bedroom

World Sleep Day: Diagnosing chronic respiratory diseases from within the bedroom

Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

Study shows BCG vaccination reduces SARS-CoV-2-induced lung inflammation in hamsters

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Characteristics of super-spreaders of novel coronaviruses

Characteristics of super-spreaders of novel coronaviruses

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Innate and adaptive immune responses to BNT162b2 vaccination in mice

Hypoxia-inducible factors and SARS-CoV-2 manifestations

Hypoxia-inducible factors and SARS-CoV-2 manifestations

Scientists develop virus-blocking textile that effectively repulses SARS-CoV-2

Scientists develop virus-blocking textile that effectively repulses SARS-CoV-2

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

The Future of Tuberculosis; An Interview with Gates MRI

The Future of Tuberculosis; An Interview with Gates MRI

Final Research Plan: Cervical Cancer: Screening | United States Preventive Services Taskforce

Final Research Plan: Cervical Cancer: Screening | United States Preventive Services Taskforce

SOPS Medical Office Database | Agency for Healthcare Research and Quality

SOPS Medical Office Database | Agency for Healthcare Research and Quality

CDRHNew - News and Updates | FDA

CDRHNew - News and Updates | FDA

Human Gene Therapy Products Incorporating Human Genome Editing | FDA

Human Gene Therapy Products Incorporating Human Genome Editing | FDA

Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products | FDA

Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products | FDA

CDC Proposes Updating Practice Guideline for Prescribing Opioids, Warning Against Continued Misapplication

CDC Proposes Updating Practice Guideline for Prescribing Opioids, Warning Against Continued Misapplication

Postpartum Care for Women Up to One Year After Pregnancy | Effective Health Care (EHC) Program

Postpartum Care for Women Up to One Year After Pregnancy | Effective Health Care (EHC) Program

Strategies for Integrating Behavioral Health and Primary Care | Effective Health Care (EHC) Program

Strategies for Integrating Behavioral Health and Primary Care | Effective Health Care (EHC) Program

Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Annual Update #1 | Effective Health Care (EHC) Program

Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Annual Update #1 | Effective Health Care (EHC) Program

FDA Newsroom | FDA

FDA Newsroom | FDA

Through-Container Quantitative Screening of Hand Sanitizers | FDA

Through-Container Quantitative Screening of Hand Sanitizers | FDA

What’s New for Biologics | FDA

What’s New for Biologics | FDA

jueves, 17 de marzo de 2022

Highlighting Youth Gaming and Gambling Risks and Strategies for Prevention | Prevention Technology Transfer Center (PTTC) Network

Highlighting Youth Gaming and Gambling Risks and Strategies for Prevention | Prevention Technology Transfer Center (PTTC) Network

The Landscape is Getting Greener: A Series on the Current Science of Cannabis | Addiction Technology Transfer Center (ATTC) Network

The Landscape is Getting Greener: A Series on the Current Science of Cannabis | Addiction Technology Transfer Center (ATTC) Network

Dr. Brian Boyd presents: Exploring the Consequences of Bias and Structural Racism on Service Disparities in Autism | Mental Health Technology Transfer Center (MHTTC) Network

Dr. Brian Boyd presents: Exploring the Consequences of Bias and Structural Racism on Service Disparities in Autism | Mental Health Technology Transfer Center (MHTTC) Network

Prevention Specialist Credentialing: It's not as scary as you might imagine! | Prevention Technology Transfer Center (PTTC) Network

Prevention Specialist Credentialing: It's not as scary as you might imagine! | Prevention Technology Transfer Center (PTTC) Network

Reclaiming Native Psychological Brilliance | Mental Health Technology Transfer Center (MHTTC) Network

Reclaiming Native Psychological Brilliance | Mental Health Technology Transfer Center (MHTTC) Network